Physician profile
Arnold Saha
NPI 1770726796
$44,777.58
in general payments reported to CMS, 2019-2025
11 companies · $62.92 in 2025
The $62.92 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $20.66 · 2021: $107 · 2022: $138 · 2023: $61.68 · 2024: $44K · 2025: $62.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $43K · Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $43,416.67 |
| Food and Beverage | $590.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $43,516.44 | 2024 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Nevro Corp. | $303.42 | 2024 | Senza |
| Sirtex Medical INC | $260.92 | 2019 | |
| Terumo Medical Corporation | $127.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $123.23 | 2022 | |
| Eisai INC. | $117.32 | 2019 | |
| Abbott Laboratories | $116.06 | 2021-2025 | Armada |
| Boston Scientific Corporation | $102.81 | 2022-2025 | Varithena Administration Pack, Jetstream Sc |
| Siemens Medical Solutions USA, INC. | $53.44 | 2024-2025 | Embozene |
| Bard Peripheral Vascular, INC. | $31.80 | 2020-2021 | |
| Medtronic, INC. | $25.04 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Saha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.